Clinical Trials Logo
  1. Home
  2. Symptoms and Signs
  3. NCT05729217
  4. Details
NCT05729217 Clinical Trial

Long COVID Symptoms in SARS-CoV-2-positive Children in China

Symptoms and Signs Clinical Trial

Official title:
Long COVID Symptoms in SARS-CoV-2-positive Children Aged 6-18 Years in China: a Consequential Observation Study

Clinical Trial Details — Status: Active, not recruiting

Administrative data
NCT number NCT05729217
Other study ID # Children COVID Symptoms
Secondary ID
Status Active, not recruiting
Phase
First received
Last updated
Start date February 1, 2023
Est. completion date January 31, 2024

Study information
Verified date February 2023
Source GlobalMD Organization Network Corp
Contact n/a
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

The goal of this observational study is to learn about in children aged 6-18 years, after the acute phase of SARS-CoV-2 infection, the COVID symptoms or Long COVID symptoms to impact their daily activities. We aimed to investigate the prevalence of long-lasting symptoms, the duration and intensity of symptoms, quality of life, number of sick days or absences from school, and psychological and social outcomes. The participants will be asked to fill in Long COVID symptom burden questionnaires who had been infected with SARS-CoV-2 as self-reported PRC test or antigen test positive.

Description:

The goal of this observational study is to learn about in children aged 6-18 years, after the acute phase of SARS-CoV-2 infection, the COVID symptoms or Long COVID symptoms to impact their daily activities. We aimed to investigate the prevalence of long-lasting symptoms, the duration and intensity of symptoms, quality of life, number of sick days or absences from school, and psychological and social outcomes. The participants will be asked to fill in SBQ-Long COVID symptom burden survey questionnaires who had been infected with SARS-CoV-2 as self-reported PRC test or antigen test positive. The survey questionnaires will be filled every two weeks after the participants have been tested SARS-CoV-2 positive.

Recruitment information / eligibility
Status Active, not recruiting
Enrollment 5000
Est. completion date January 31, 2024
Est. primary completion date January 31, 2024
Accepts healthy volunteers No
Gender All
Age group 7 Years to 18 Years
Eligibility Inclusion Criteria: infected with SARS-CoV-2 as self-reported PRC test or antigen test positive or have symptoms, but without Covid-19 test. Exclusion Criteria: aged below 6 years or above 18 years

Study Design

Related Conditions & MeSH terms

Intervention

Other:
• SBQ-LC survey
Symptom burden questionnaires of Long COVID

Locations
Country Name City State
China Capital Institute of Pediatrics Beijing

Sponsors (2)
Lead Sponsor Collaborator
Tim Shi Capital Institute of Pediatrics, China

Country where clinical trial is conducted

China, 

Outcome
Type Measure Description Time frame Safety issue
Primary long symptoms of SARS-CoV-2 the prevalence of long-lasting symptoms, the duration and intensity of symptoms 6 to 12 weeks
Primary absences from school number of sick days or absences from school, and psychological and social outcomes. 24 weeks
See also
  Status Clinical Trial Phase
Completed NCT04892004 - Symptom Recognition Improves Self-care in Patients With Heart Failure. N/A
Recruiting NCT06446999 - Yoga-Based Breathing Exercise, Colorectal Cancer Surgery N/A
Not yet recruiting NCT05505188 - Predictive and Impact of Pain After 6 Months of Radiotherapy, in Head and Neck Cancer N/A
Completed NCT04864600 - CANDLE - A Study of Acute Health Effects of Exposure to Particles Generated by Candles N/A
Completed NCT03336177 - Understanding Low Gynecological Cancer Delay and Help-seeking Behavior in Older Patients.
Completed NCT06395025 - Blinded User Study for the Evaluation of the Acceptability and Efficacy of One Medical Device in Venous Return in Comparison With a Control Group N/A
Completed NCT04292665 - Effects of Classical Massage and Benson Relaxation Exercise on Heart Failure Patients N/A
Recruiting NCT05680831 - Pulmonary and Inflammatory Responses Following Exposure to a Low Concentration of Ozone or Clean Air Phase 1
Recruiting NCT05681975 - Immunoglobulin G4 and Immunoglobulin E Antibodies in a Population With Adverse Reactions to Foodstuffs-related Symptoms
Completed NCT04169919 - Modified Treatment for Epidemic Keratoconjunctivitis (EKC) N/A
Recruiting NCT06436651 - Digital Storytelling in Symptom Management Pediatric Oncology N/A
Recruiting NCT04940780 - Integrative Oncology for Patient Symptoms N/A
Not yet recruiting NCT05837988 - Construction of Symptom Network in Maintenance Hemodialysis Patients
Recruiting NCT05092568 - Comparison of General Characteristics of Patients Diagnosed COVID-19 (Coronavirus )Positive Followed In Service
Recruiting NCT03968718 - PATIENT VOICES Integration of Systematic Assessment of Patient Reported Outcomes Within Clinical Oncology Practice N/A
Completed NCT05556707 - Symptom Clusters and Risk Factors of COVID-19 Patients
Completed NCT06153680 - Consumer Study for the Evaluation of the Usability and Efficacy of One Medical Device in Venous Return N/A
Completed NCT04873349 - Standardized Olive Leaf Capsules; as a Co-therapy in the Treatment of COVID-19 Patients N/A
Recruiting NCT06136221 - Testing LiverWatch, a Home-Based Remote-Monitoring Intervention for Advanced Liver Disease N/A
Recruiting NCT05827406 - A Useful Support System for Psychiatric Diagnostics and Follow-up in Adult Psychiatry and Primary Care (ASPP)